These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 1687786)

  • 1. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
    Fujiwara S; Arita M; Ueno Y; Shiotani M; Nakatsu C; Nakamura Y; Hano T; Nishio I; Masuyama Y
    J Cardiol; 1991; 21(1):115-24. PubMed ID: 1687786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic cardiac influence and arterial blood pressure instability.
    Formes KJ; Wray DW; O-Yurvati AH; Weiss MS; Shi X
    Auton Neurosci; 2005 Mar; 118(1-2):116-24. PubMed ID: 15795185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension.
    Omvik P; Lund-Johansen P
    Ann Clin Res; 1988; 20 Suppl 48():23-30. PubMed ID: 3250315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P; Roudaut R; Herrero G; Dallocchio M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise-induced modifications in cardiorespiratory parameters of hypertensive patients treated with calcium antagonists.
    Fariello R; Boni E; Corda L; Muiesan ML; Agabiti-Rosei E
    J Hypertens Suppl; 1991 Dec; 9(3):S67-72. PubMed ID: 1686784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension].
    Serro-Azul JB; Wajngarten M; Santomauro A; Braga A; Yazbek Júnior P; Bellotti G; Serro-Azul LG; Pileggi F
    Arq Bras Cardiol; 1989 Dec; 53(6):321-5. PubMed ID: 2700113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
    Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H; Seiler A; Mahler F
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pattern of left ventricular hypertrophy in hypertension and its relation to the hemodynamic and sympathetic responses to exercise].
    Arita M; Ueno Y; Fujiwara S; Hamada M; Hano T; Nishio I; Masuyama Y
    J Cardiogr; 1986 Mar; 16(1):95-104. PubMed ID: 2946785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation.
    Banaszewski M; Rydlewska-Sadowska W; Rubkiewicz S
    J Heart Valve Dis; 1998 Sep; 7(5):488-99. PubMed ID: 9793844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects.
    Lang CC; Stein CM; He HB; Wood AJ
    Clin Pharmacol Ther; 1996 Jun; 59(6):668-74. PubMed ID: 8681492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise.
    van Baak MA; Böhm RO; Arends BG; van Hooff ME; Rahn KH
    Int J Sports Med; 1987 Oct; 8(5):342-7. PubMed ID: 2890591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age hemodynamics and exercise in essential hypertension: difference between beta-blockers and dihydropyridine calcium antagonists.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S7-13. PubMed ID: 2483573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of calcium antagonists in the treatment of essential hypertension.
    Klein W; Brandt D; Vrecko K; Härringer M
    Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.